Postmenopausal breast cancer, androgens, and aromatase inhibitors C. CampagnoliP. PasanisiF. Berrino Review 10 April 2013 Pages: 1 - 11
Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysis Flora Zagouri Theodoros N. SergentanisMatthias Preusser Review 16 April 2013 Pages: 13 - 22
Characteristics of basal cytokeratin expression in breast cancer Alaa T. AlshareedaDaniele SoriaAndrew R. Green Preclinical study 16 April 2013 Pages: 23 - 37
Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifen Diana E. Ramirez-ArdilaJean C. HelmijrMaurice P. H. M. Jansen Preclinical study 17 April 2013 Pages: 39 - 49
DJ-1 protein expression as a predictor of pathological complete remission after neoadjuvant chemotherapy in breast cancer patients Takahiko KawateKeiichi IwayaNorio Kohno Preclinical study 17 April 2013 Pages: 51 - 59
Determination of clinically therapeutic endoxifen concentrations based on efficacy from human MCF7 breast cancer xenografts Inna Y. GongWendy A. TeftEdna F. Choo Preclinical Study 19 April 2013 Pages: 61 - 69
Estrogen receptor α is the major driving factor for growth in tamoxifen-resistant breast cancer and supported by HER/ERK signaling Susan ThraneAnne E. LykkesfeldtChristina W. Yde Preclinical study 23 April 2013 Pages: 71 - 80
Dynamics of lymphatic regeneration and flow patterns after lymph node dissection Katrin S. BlumSteven T. ProulxMichael Detmar Preclinical study 24 April 2013 Pages: 81 - 86
Intraoperative molecular analysis of total tumor load in sentinel lymph node: a new predictor of axillary status in early breast cancer patients Vicente PegMartín Espinosa-BravoIsabel T. Rubio Clinical Trial 11 April 2013 Pages: 87 - 93
CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapy Wendy A. TeftInna Y. GongRichard B. Kim Clinical trial 12 April 2013 Pages: 95 - 105
A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer Shanu ModiCristina SauraJose Baselga Clinical trial Open access 12 April 2013 Pages: 107 - 113
The impact of breast cosmetic and functional outcomes on quality of life: long-term results from the St. George and Wollongong randomized breast boost trial Eric HauLois BrownePeter H. Graham Clinical trial 12 April 2013 Pages: 115 - 123
A longitudinal study of shoulder and arm morbidity in breast cancer survivors 7 years after sentinel lymph node biopsy or axillary lymph node dissection Jan J. KootstraPieter U. DijkstraJosette E. H. M. Hoekstra-Weebers Clinical Trial 16 April 2013 Pages: 125 - 134
Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancer Michelle A. RudekRoisin M. ConnollyAntonio C. Wolff Clinical trial 16 April 2013 Pages: 135 - 143
A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer Cynthia X. MaVera J. SumanGini F. Fleming Clinical trial 19 April 2013 Pages: 145 - 153
Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program Pål MøllerAstrid StormorkenLovise Mæhle Clinical trial 25 April 2013 Pages: 155 - 161
Dietary flavonoid and lignan intake and breast cancer risk according to menopause and hormone receptor status in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study Raul Zamora-RosPietro FerrariIsabelle Romieu Epidemiology 10 April 2013 Pages: 163 - 176
Poor compliance with breast cancer treatment guidelines in men undergoing breast-conserving surgery Jordan M. CloydTina Hernandez-BoussardIrene L. Wapnir Epidemiology 10 April 2013 Pages: 177 - 182
Stage at diagnosis and mortality in women with pregnancy-associated breast cancer (PABC) Anna L. V. JohanssonTherese M.-L. AnderssonMats Lambe Epidemiology 11 April 2013 Pages: 183 - 192
Prevalence of germline TP53 mutations in HER2+ breast cancer patients Michelle G. RathSerena MasciariJudy E. Garber Epidemiology 12 April 2013 Pages: 193 - 198
Age-related longitudinal changes in depressive symptoms following breast cancer diagnosis and treatment Nancy E. AvisBeverly LevineKimberly J. Van Zee Epidemiology 16 April 2013 Pages: 199 - 206
Narrowing racial gaps in breast cancer chemotherapy initiation: the role of the patient–provider relationship Vanessa B. SheppardClaudine IsaacsJeanne S. Mandelblatt Epidemiology 16 April 2013 Pages: 207 - 216
The effect of atmospheric particulate matter on survival of breast cancer among US females Hui HuAmy B. DaileyXiaohui Xu Epidemiology 17 April 2013 Pages: 217 - 226
Comorbidities and breast cancer survival: a report from the Shanghai Breast Cancer Survival Study Sarah NechutaWei LuXiao Ou Shu Epidemiology 19 April 2013 Pages: 227 - 235
Reproductive factors and the risk of breast cancer in old age: a Norwegian cohort study Julie HornBjørn Olav ÅsvoldLars J. Vatten Epidemiology 19 April 2013 Pages: 237 - 243
Alcohol intake over the life course and breast cancer survival in Western New York exposures and breast cancer (WEB) study: quantity and intensity of intake Anne M. WeaverSusan E. McCannJo L. Freudenheim Epidemiology 19 April 2013 Pages: 245 - 253
Association between sex hormones, glucose homeostasis, adipokines, and inflammatory markers and mammographic density among postmenopausal women Christy G. WoolcottKerry S. CourneyaChristine M. Friedenreich Epidemiology 21 April 2013 Pages: 255 - 265
Association between a novel polymorphism (rs2046210) of the 6q25.1 locus and breast cancer risk Ziang YangJuping ShenBiyun Wang Epidemiology 23 April 2013 Pages: 267 - 275
Radial scars and subsequent breast cancer risk: results from the Nurses’ Health Studies Sarah A. AronerLaura C. CollinsRulla M. Tamimi Epidemiology 23 April 2013 Pages: 277 - 285
Improper use of “radioguided occult lesion localization” (ROLL) technique leads to misleading conclusions Giovanni PaganelliLaura GilardiUmberto Veronesi Letter To the Editor 24 April 2013 Pages: 287 - 290
Letter to the Editor, Re: Night-shift work and risk of breast cancer (Kamdar et al., doi:10.1007/s10549-013-2433-1) Richard StevensJohnni Hansen Letter to the Editor 25 April 2013 Pages: 291 - 294
Erratum to: Which nomogram is best for predicting non-sentinel lymph node metastasis in breast cancer patients? A meta-analysis Liling ZhuLiang JinFengxi Su Erratum 17 April 2013 Pages: 295 - 300
